Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 23 | 2024 | 11336 | 1.630 |
Why?
|
Prostatic Hyperplasia | 5 | 2022 | 530 | 1.580 |
Why?
|
Prostatectomy | 9 | 2023 | 1956 | 1.230 |
Why?
|
Ablation Techniques | 4 | 2023 | 248 | 0.960 |
Why?
|
Transurethral Resection of Prostate | 2 | 2022 | 85 | 0.820 |
Why?
|
Urethral Obstruction | 1 | 2022 | 56 | 0.820 |
Why?
|
Urology | 5 | 2024 | 423 | 0.770 |
Why?
|
Laser Therapy | 3 | 2023 | 1089 | 0.740 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2024 | 2276 | 0.660 |
Why?
|
Circumcision, Male | 1 | 2020 | 148 | 0.650 |
Why?
|
Mentors | 1 | 2023 | 660 | 0.610 |
Why?
|
Travel | 1 | 2023 | 785 | 0.570 |
Why?
|
Prostate-Specific Antigen | 9 | 2024 | 2528 | 0.560 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5403 | 0.530 |
Why?
|
Healthcare Disparities | 4 | 2024 | 3362 | 0.530 |
Why?
|
Muscles | 1 | 2021 | 1579 | 0.520 |
Why?
|
Robotics | 1 | 2023 | 874 | 0.520 |
Why?
|
Urinary Bladder | 2 | 2023 | 1166 | 0.510 |
Why?
|
Military Personnel | 1 | 2024 | 1244 | 0.490 |
Why?
|
Laparoscopy | 2 | 2023 | 2147 | 0.470 |
Why?
|
Early Detection of Cancer | 6 | 2023 | 3211 | 0.460 |
Why?
|
Androgen Antagonists | 2 | 2022 | 1442 | 0.450 |
Why?
|
Ureteral Calculi | 2 | 2021 | 116 | 0.320 |
Why?
|
Nomograms | 2 | 2021 | 237 | 0.320 |
Why?
|
Relative Value Scales | 2 | 2024 | 86 | 0.280 |
Why?
|
Quality of Life | 4 | 2023 | 13286 | 0.280 |
Why?
|
Male | 42 | 2024 | 358742 | 0.270 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2023 | 117 | 0.240 |
Why?
|
Humans | 57 | 2024 | 758381 | 0.230 |
Why?
|
United States | 20 | 2024 | 72140 | 0.220 |
Why?
|
Internship and Residency | 1 | 2023 | 5865 | 0.220 |
Why?
|
Kidney Neoplasms | 3 | 2024 | 4312 | 0.200 |
Why?
|
Military Medicine | 1 | 2024 | 186 | 0.200 |
Why?
|
Periodicals as Topic | 2 | 2023 | 1462 | 0.200 |
Why?
|
Keratin-5 | 1 | 2021 | 45 | 0.190 |
Why?
|
Keratin-14 | 1 | 2021 | 56 | 0.190 |
Why?
|
Finasteride | 1 | 2022 | 90 | 0.190 |
Why?
|
Renal Colic | 1 | 2021 | 28 | 0.180 |
Why?
|
State Medicine | 1 | 2022 | 213 | 0.180 |
Why?
|
GATA3 Transcription Factor | 1 | 2021 | 152 | 0.180 |
Why?
|
Lebanon | 1 | 2021 | 245 | 0.170 |
Why?
|
Telemetry | 1 | 2021 | 199 | 0.170 |
Why?
|
Erectile Dysfunction | 1 | 2023 | 451 | 0.170 |
Why?
|
Retrospective Studies | 15 | 2024 | 80170 | 0.170 |
Why?
|
Hydronephrosis | 1 | 2021 | 271 | 0.160 |
Why?
|
Remission, Spontaneous | 1 | 2019 | 384 | 0.160 |
Why?
|
Urinary Incontinence | 1 | 2023 | 495 | 0.160 |
Why?
|
Medicare | 4 | 2024 | 6741 | 0.160 |
Why?
|
Specialties, Surgical | 1 | 2023 | 388 | 0.160 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2022 | 357 | 0.160 |
Why?
|
Pilot Projects | 2 | 2023 | 8554 | 0.160 |
Why?
|
Carcinoma, Renal Cell | 2 | 2024 | 3217 | 0.150 |
Why?
|
Water | 2 | 2021 | 1402 | 0.150 |
Why?
|
Androgens | 2 | 2022 | 1291 | 0.150 |
Why?
|
Pancreatitis | 1 | 2023 | 1098 | 0.130 |
Why?
|
Aged | 13 | 2024 | 168217 | 0.130 |
Why?
|
Cystectomy | 1 | 2021 | 697 | 0.130 |
Why?
|
Prostate | 4 | 2023 | 1791 | 0.120 |
Why?
|
Cisplatin | 1 | 2021 | 1645 | 0.120 |
Why?
|
Postoperative Complications | 5 | 2023 | 15638 | 0.120 |
Why?
|
Health Status Disparities | 2 | 2023 | 1832 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 2 | 2024 | 6493 | 0.110 |
Why?
|
Biological Products | 1 | 2023 | 906 | 0.110 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2022 | 1530 | 0.110 |
Why?
|
Qualitative Research | 1 | 2024 | 2976 | 0.110 |
Why?
|
Anesthetics, Local | 1 | 2020 | 1000 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1064 | 0.110 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2023 | 1406 | 0.110 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2023 | 1370 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3617 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2610 | 0.100 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2943 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3527 | 0.100 |
Why?
|
Middle Aged | 13 | 2024 | 219560 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2024 | 2049 | 0.100 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25953 | 0.100 |
Why?
|
Massachusetts | 1 | 2024 | 8823 | 0.090 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1919 | 0.090 |
Why?
|
Crohn Disease | 1 | 2023 | 2275 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2024 | 64379 | 0.090 |
Why?
|
Patient Discharge | 1 | 2023 | 3433 | 0.090 |
Why?
|
Blood Platelets | 1 | 2020 | 2475 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2022 | 11152 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4020 | 0.080 |
Why?
|
Watchful Waiting | 2 | 2023 | 509 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 5484 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2420 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13245 | 0.080 |
Why?
|
Lymphocyte Count | 2 | 2020 | 778 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2631 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3755 | 0.070 |
Why?
|
SEER Program | 2 | 2023 | 1530 | 0.070 |
Why?
|
Platelet Count | 2 | 2020 | 775 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58681 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11070 | 0.070 |
Why?
|
Mass Screening | 1 | 2023 | 5425 | 0.070 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1718 | 0.070 |
Why?
|
Telemedicine | 1 | 2023 | 3018 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5248 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4745 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5065 | 0.060 |
Why?
|
Logistic Models | 3 | 2023 | 13276 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5246 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13468 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10146 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 29558 | 0.050 |
Why?
|
Mesalamine | 1 | 2023 | 136 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 412 | 0.050 |
Why?
|
Efficiency | 1 | 2024 | 477 | 0.050 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2021 | 213 | 0.050 |
Why?
|
Female | 7 | 2024 | 390316 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 26182 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 54136 | 0.040 |
Why?
|
Adult | 9 | 2024 | 219916 | 0.040 |
Why?
|
Learning Curve | 1 | 2022 | 231 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2024 | 696 | 0.040 |
Why?
|
Pandemics | 3 | 2023 | 8611 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2023 | 465 | 0.040 |
Why?
|
Advisory Committees | 1 | 2023 | 785 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36054 | 0.040 |
Why?
|
Editorial Policies | 1 | 2023 | 456 | 0.040 |
Why?
|
Probability | 1 | 2023 | 2467 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2111 | 0.040 |
Why?
|
Alopecia | 1 | 2022 | 414 | 0.040 |
Why?
|
Nephrectomy | 1 | 2022 | 1016 | 0.030 |
Why?
|
Tumor Burden | 1 | 2022 | 1893 | 0.030 |
Why?
|
Smoking | 2 | 2024 | 9042 | 0.030 |
Why?
|
Databases, Factual | 2 | 2024 | 7980 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2024 | 772 | 0.030 |
Why?
|
Ethanol | 1 | 2022 | 1325 | 0.030 |
Why?
|
Pelvis | 1 | 2020 | 743 | 0.030 |
Why?
|
Publishing | 1 | 2023 | 833 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2022 | 1078 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1754 | 0.030 |
Why?
|
Quality Improvement | 2 | 2021 | 3806 | 0.030 |
Why?
|
Income | 1 | 2024 | 1872 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21273 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1090 | 0.030 |
Why?
|
Language | 1 | 2024 | 1532 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1303 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2322 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1116 | 0.030 |
Why?
|
Cost of Illness | 1 | 2023 | 1936 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2023 | 4901 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22030 | 0.030 |
Why?
|
Survivors | 1 | 2023 | 2371 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7225 | 0.030 |
Why?
|
Risk Assessment | 2 | 2023 | 23883 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2348 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5199 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 3990 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3261 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3888 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3846 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2551 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7016 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8176 | 0.020 |
Why?
|
Lung | 1 | 2024 | 9985 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15225 | 0.010 |
Why?
|
Depression | 1 | 2023 | 8057 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7810 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10719 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29915 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41252 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36285 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 73806 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 58808 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 87888 | 0.010 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_